INTRODUCTION

Introduction to Cord Blood Special Issue
Bone Marrow Transplantation (2009) 44, 619; doi:10.1038 /bmt.2009 In 1989, the New England Journal of Medicine published the report of the first cord blood transplant in a French boy with Fanconi's anemia. In the United States, where many of the basic science experiments had been performed, George HW Bush was President and a gallon of gas could be purchased for 97 cents. Elsewhere, political protests and reform caused dramatic changes. In 1989, France celebrated the 200th anniversary of the French Revolution, the Berlin Wall toppled and Chinese students resisted authorities at Tiananmen Square. This spirit of innovation, international collaboration and advancement helped to gather the enterprise and expertise for the first cord blood transplant and provides a powerful force in the cord blood field today.
Since 1989, umbilical cord blood banks have been established in six continents and over one million cord blood collections have been performed. Standards for cord blood banking and processing have been established. Approximately 10 000 cord blood transplants have been performed in children and adults, for malignant and nonmalignant conditions.
In this issue, we are fortunate to have the pioneers from the first cord blood transplant 20 years ago (Drs Gluckman and Broxmeyer) share their perspective on the history of cord blood transplants and the scientific advances that facilitated this achievement. Dr Rubinstein describes the origins and successes of the New York Blood Center, which has supplied units to over 3000 patients in 100 different transplant centers. The growth of the pediatric experience is chronicled by Dr Rocha and Dr Kurtzberg. Dr Ooi presents the spectacular results in adult transplants from Japan. Dr Cutler reviews the extension to reduced intensity transplantation, and Dr Sphall highlights the interest in expansion techniques. Finally, Drs Kogler and Brunstein foreshadow the future of the cord blood field-how cord blood transplantation may appear in 20 years, say, in 2029.
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